Dysregulated NOD2 predisposes SAMP1/YitFc mice to chronic intestinal inflammation
- Daniele Corridoni,
- Tomohiro Kodani,
- Alexander Rodriguez-Palacios,
- Theresa T. Pizarro,
- Wei Xin,
- Kourtney P. Nickerson
- Case Western Reserve University,
- Cleveland Clinic Foundation,
- ,
- ,
- ,
- La Jolla Institute for Allergy and Immunology
Open access
Abstract
Nucleotide-binding oligomerization domain-containing 2 (NOD2) is an intracellular receptor that plays an essential role in innate immunity as a sensor of a component of the bacterial cell wall, muramyl dipeptide (MDP). Crohn's disease (CD)-associated NOD2 variants lead to defective innate immune responses, including decreased NF-κB activation and cytokine production. We report herein that SAMP1/YitFc (SAMP) mice, which develop spontaneous CD-like ileitis in the absence of NOD2 genetic mutations, fail to respond to MDP administration by displaying decreased innate cytokine production and dysregulated NOD2 signaling compared with parental AKR control mice. We show that, unlike in other mouse strains, in vivo administration of MDP does not prevent dextran sodium sulfate-induced colitis in SAMP mice and that the abnormal NOD2 response is specific to the hematopoietic cellular component. Moreover, we demonstrate that MDP fails to enhance intracellular bacterial killing in SAMP mice. These findings shed important light on the initiating molecular events underlying CD-like ileitis.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 16999-17004 (6 pages)Journal (Volume, Issue Number)
Proceedings of the National Academy of Sciences of the United States of America (Volume 110, Issue 42)Publication milestones
- Published - 10/15/2013
Publication status
ISSN
0027-8424Publication IDs
- Scopus: 84885698235
- PubMed: 24082103
